Pliant Therapeutics (PLRX) Total Current Liabilities (2019 - 2025)
Historic Total Current Liabilities for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $17.6 million.
- Pliant Therapeutics' Total Current Liabilities fell 5588.71% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year decrease of 5588.71%. This contributed to the annual value of $33.2 million for FY2024, which is 1645.63% up from last year.
- According to the latest figures from Q3 2025, Pliant Therapeutics' Total Current Liabilities is $17.6 million, which was down 5588.71% from $20.6 million recorded in Q2 2025.
- In the past 5 years, Pliant Therapeutics' Total Current Liabilities registered a high of $40.0 million during Q3 2024, and its lowest value of $10.2 million during Q1 2021.
- In the last 5 years, Pliant Therapeutics' Total Current Liabilities had a median value of $23.9 million in 2022 and averaged $23.8 million.
- In the last 5 years, Pliant Therapeutics' Total Current Liabilities soared by 10630.26% in 2022 and then plummeted by 5588.71% in 2025.
- Quarter analysis of 5 years shows Pliant Therapeutics' Total Current Liabilities stood at $16.8 million in 2021, then surged by 42.08% to $23.9 million in 2022, then grew by 19.28% to $28.5 million in 2023, then rose by 16.46% to $33.2 million in 2024, then plummeted by 46.94% to $17.6 million in 2025.
- Its Total Current Liabilities was $17.6 million in Q3 2025, compared to $20.6 million in Q2 2025 and $28.2 million in Q1 2025.